| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |